Guardant Health (GH) Operating Income (2017 - 2026)

Guardant Health has disclosed Operating Income across 10 years of filings, most recently posting -$121.4 million for Q1 2026.

• Operating Income for Q1 2026 came in at -$121.4 million, down 9.28% year-over-year; the trailing twelve-month figure through Mar 2026 was -$447.6 million (up 1.63% YoY), and the FY2025 annual result was -$437.2 million, up 1.43% from the prior year.
• Operating Income came in at -$121.4 million for Q1 2026 at Guardant Health, roughly flat from -$120.8 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of -$99.0 million in Q3 2025 to a low of -$197.5 million in Q4 2023.
• The 5-year median for Operating Income is -$120.8 million (2025), against an average of -$124.2 million.
• Across the five-year window, Operating Income slumped 48.79% in 2022 and surged 36.22% in 2024, its largest moves.
• Guardant Health's Operating Income stood at -$146.1 million in 2022, then slumped by 35.17% to -$197.5 million in 2023, then soared by 36.22% to -$126.0 million in 2024, then rose by 4.1% to -$120.8 million in 2025, then retreated by 0.45% to -$121.4 million in 2026.
• The last three Operating Income figures came in at -$121.4 million (Q1 2026), -$120.8 million (Q4 2025), and -$99.0 million (Q3 2025), per Business Quant data.